Rui Avelar
Chief Medical Officer and Head of R&D; Chief Medical Officer and Head of Research & Development; Officer · 3 filings · Latest: Mar 20, 2026
Evolus, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
EOLS | Rui Avelar | Officer | Mar 20, 2026 | Sale | $4.75 | 3,119 | $14.8K | 427,423 | |
EOLS | Rui Avelar | Chief Medical Officer and Head of Research & Development | Mar 17, 2026 | Sale | $4.89 | 29,996 | $146.6K | 430,542 | |
EOLS | Rui Avelar | Chief Medical Officer and Head of Research & Development | Mar 16, 2026 | Option Exercise | $0.00 | 8,804 | — | 460,538 |